stockportfolio.pro
Avanos Medical, Inc. (AVNS)
Healthcare · Medical Devices · NYSE
Avanos Medical, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $566.20M | $611.60M | $652.30M | $697.60M | $714.80M | $587.00M | $820.00M | $673.30M | $687.80M | $701.20M |
| Gross profit | $297.20M | $336.90M | $390.90M | $402.20M | $370.90M | $299.20M | $394.20M | $379.70M | $381.30M | $353.90M |
| Net income | $39.80M | $79.30M | $57.50M | $-45.90M | $-29.00M | $6.30M | $50.50M | $-61.80M | $-392.10M | $-72.90M |
| Net margin | 7.0% | 13.0% | 8.8% | -6.6% | -4.1% | 1.1% | 6.2% | -9.2% | -57.0% | -10.4% |
Source: Avanos Medical, Inc. SEC filings (10-K). 14 years of history available in the interactive view.
Explore 14 years of Avanos Medical, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track AVNS in your portfolio →
About Avanos Medical, Inc.
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Avanos Medical, Inc. — frequently asked questions
What is Avanos Medical, Inc.'s revenue?
Avanos Medical, Inc. (AVNS) reported revenue of $701.20M for fiscal year 2025, up 1.9% from the prior year, according to its SEC filings.
Is Avanos Medical, Inc. profitable?
No — AVNS reported a net loss of $-72.90M in fiscal 2025.
What is AVNS's P/E ratio?
Avanos Medical, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Avanos Medical, Inc. growing?
AVNS's revenue grew at roughly -0.4% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
Where does this data come from?
All figures are computed from Avanos Medical, Inc.'s official SEC filings (10-K and 10-Q), covering 14 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.